title: Personalizing HER2-targeted therapy in metastatic breast cancer beyond HER2 status: what we have learned from clinical specimens.
authors.affiliation: Department of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322.
authors.forename: R
authors.initials: R
authors.lastname: Nahta
authors.forename: S
authors.initials: S
authors.lastname: Shabaya
authors.forename: T
authors.initials: T
authors.lastname: Ozbay
authors.forename: D L
authors.initials: DL
authors.lastname: Rowe